Barlow Wealth Partners Inc. Takes $100,000 Position in Alignment Healthcare, Inc. (NASDAQ:ALHC)

Barlow Wealth Partners Inc. bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 11,668 shares of the company’s stock, valued at approximately $100,000.

Other hedge funds have also bought and sold shares of the company. Teza Capital Management LLC purchased a new stake in shares of Alignment Healthcare during the 3rd quarter valued at $109,000. Victory Capital Management Inc. lifted its stake in Alignment Healthcare by 17.9% during the fourth quarter. Victory Capital Management Inc. now owns 12,935 shares of the company’s stock worth $111,000 after purchasing an additional 1,962 shares during the last quarter. Aigen Investment Management LP purchased a new position in shares of Alignment Healthcare in the 3rd quarter worth about $116,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Alignment Healthcare by 75.5% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,427 shares of the company’s stock valued at $183,000 after purchasing an additional 11,370 shares during the last quarter. Finally, Dark Forest Capital Management LP purchased a new position in shares of Alignment Healthcare during the 3rd quarter valued at about $187,000. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Trading Up 1.3 %

NASDAQ:ALHC traded up $0.09 during mid-day trading on Tuesday, reaching $6.87. 1,312,347 shares of the company’s stock traded hands, compared to its average volume of 912,560. The company has a 50 day moving average price of $5.13 and a 200-day moving average price of $6.52. The firm has a market capitalization of $1.31 billion, a price-to-earnings ratio of -8.18 and a beta of 1.23. The company has a debt-to-equity ratio of 1.23, a current ratio of 1.57 and a quick ratio of 1.57. Alignment Healthcare, Inc. has a 12-month low of $4.46 and a 12-month high of $9.20.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Thursday, May 2nd. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.24) by ($0.01). The business had revenue of $628.60 million for the quarter, compared to analysts’ expectations of $599.75 million. Alignment Healthcare had a negative net margin of 7.81% and a negative return on equity of 91.06%. Alignment Healthcare’s quarterly revenue was up 43.1% on a year-over-year basis. During the same period last year, the firm posted ($0.20) earnings per share. On average, sell-side analysts predict that Alignment Healthcare, Inc. will post -0.6 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have issued reports on the company. Piper Sandler reaffirmed a “neutral” rating and issued a $6.00 target price (down previously from $12.00) on shares of Alignment Healthcare in a research note on Wednesday, March 6th. Barclays began coverage on shares of Alignment Healthcare in a research note on Wednesday, March 6th. They issued an “underweight” rating and a $4.50 price target for the company. UBS Group reduced their price objective on Alignment Healthcare from $9.00 to $8.50 and set a “neutral” rating on the stock in a research note on Wednesday, February 28th. Stephens boosted their target price on Alignment Healthcare from $6.00 to $7.00 and gave the company an “equal weight” rating in a research note on Friday. Finally, Stifel Nicolaus dropped their target price on Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating for the company in a report on Tuesday, April 23rd. One analyst has rated the stock with a sell rating, four have issued a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Alignment Healthcare presently has an average rating of “Hold” and an average target price of $8.47.

Insiders Place Their Bets

In other news, CEO John E. Kao acquired 103,000 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were acquired at an average cost of $4.82 per share, with a total value of $496,460.00. Following the transaction, the chief executive officer now owns 2,745,253 shares in the company, valued at approximately $13,232,119.46. The acquisition was disclosed in a legal filing with the SEC, which is available at this link. In other news, CEO John E. Kao acquired 103,000 shares of the firm’s stock in a transaction on Thursday, March 14th. The stock was acquired at an average price of $4.82 per share, for a total transaction of $496,460.00. Following the completion of the acquisition, the chief executive officer now owns 2,745,253 shares in the company, valued at $13,232,119.46. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Robert Thomas Freeman sold 11,858 shares of the business’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $4.89, for a total transaction of $57,985.62. Following the sale, the chief financial officer now owns 898,228 shares in the company, valued at approximately $4,392,334.92. The disclosure for this sale can be found here. In the last ninety days, insiders sold 90,213 shares of company stock worth $460,587. 6.30% of the stock is currently owned by corporate insiders.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.